A wait time of at least 20 days to undergo elective, low-risk, cancer-related surgery appeared safe following recovery from mild to moderate COVID-19, according to study results published in Annals of Surgical Oncology.
Additionally, researchers found that patients with COVID-19 infection requiring inpatient treatment had increased risk for adverse events after surgery, and additional wait time may be required in those with more severe infections.
“As the pandemic progressed, we increasingly found ourselves taking care of [patients with cancer] who previously recovered from SARS-CoV-2